We observed a rapid and significant rise in HGF levels after surgery, reaching maximal levels on postoperative day (POD) 1 for breast and colorectal cancer patients and on POD3 for prostate cancer patients (Figure 3B–D). This evidence concerns the gene HGF and prostate carcinoma.